UQUIFA : API - generics - dossiers - pharma - GMP - FDA - regulatory

Competitiveness

Western Europe Facilities plus low cost manufacturing facilites in Mexico and India

Quality

FDA and European approvals, ISO-14001 and regularly audited by our customers and National Health Authorities

Reliability

More than 75 years of experience in the Pharmaceutical world

Sustainability

Commited with the environment, the health and the security.

Integrity

Open and transparent partnership with our customers

New Products

Strong pipeline of new API's and pharmaceutical dossiers

New web page of QSynth

24 January 2012

Visit our new webpage of QSynth

Uquifa announce creation of QSynth

24 January 2012

Uquifa SA is pleased to announce the creation of QSynth SA as its independent commercial subsidiary, with the primary mission to manage and improve its services for the CMO business to the...

Announcement of the acquisition by Vivimed Labs (India) of Uquifa

01 December 2011

Three years after the acquisition and successful realignment of James Robinson UK, Vivimed Labs is further strengthening its position in Europe and the Americas. It announced the purchase of...